Methodology-centered review of molecular modeling, simulation, and prediction of SARS-CoV-2
Despite tremendous efforts in the past two years, our understanding of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), virus–host interactions, immune …
respiratory syndrome coronavirus 2 (SARS-CoV-2), virus–host interactions, immune …
Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 Mpro Protease
Wuhan, China was the epicenter of the first zoonotic transmission of the severe acute
respiratory syndrome coronavirus clade 2 (SARS-CoV-2) in December 2019 and it is the …
respiratory syndrome coronavirus clade 2 (SARS-CoV-2) in December 2019 and it is the …
The iron (III) and nickel (II) complexes with tetradentate thiosemicarbazones. Synthesis, experimental, theoretical characterization, and antiviral effect against SARS …
The discovery of new inhibitors that can be used in the treatment of viral diseases, including
Covid-19, is an area open to research, and there is a need for innovative compounds with …
Covid-19, is an area open to research, and there is a need for innovative compounds with …
Drug repositioning to target NSP15 protein on SARS‐CoV‐2 as possible COVID‐19 treatment
Y Sixto‐López… - Journal of computational …, 2021 - Wiley Online Library
Abstract SARS‐CoV and SARS‐CoV‐2 belong to the subfamily Coronaviridae and infect
humans, they are constituted by four structural proteins: Spike glycoprotein (S), membrane …
humans, they are constituted by four structural proteins: Spike glycoprotein (S), membrane …
In silico identification of a potent arsenic based approved drug darinaparsin against SARS-CoV-2: inhibitor of RNA dependent RNA polymerase (RdRp) and essential …
T Chowdhury, G Roymahapatra… - … Disorders-Drug Targets …, 2021 - ingentaconnect.com
Background: COVID-19 is a life-threatening novel corona viral infection to our civilization
and spreading rapidly. Tremendousefforts have been made by the researchers to search for …
and spreading rapidly. Tremendousefforts have been made by the researchers to search for …
Drug repositioning by merging active subnetworks validated in cancer and COVID-19
M Lucchetta, M Pellegrini - Scientific Reports, 2021 - nature.com
Computational drug repositioning aims at ranking and selecting existing drugs for novel
diseases or novel use in old diseases. In silico drug screening has the potential for speeding …
diseases or novel use in old diseases. In silico drug screening has the potential for speeding …
[PDF][PDF] The New Technologies in the Pandemic Era
EGS Nascimento, AN Furtado, R Badaró… - JOURNAL OF …, 2020 - researchgate.net
The pandemic of the new coronavirus affected people's lives by an unprecedented scale.
Due to the need for isolation and the treatments, drugs, and vaccines, the pandemic …
Due to the need for isolation and the treatments, drugs, and vaccines, the pandemic …
An Integrative Drug Repurposing Pipeline Using KNIME and Programmatic Data Access: a Case Study on COVID-19 Data
A Tuerkova, B Zdrazil - 2020 - chemrxiv.org
Biomedical information mining is increasingly recognized as a promising technique to
accelerate drug discovery and development. Especially, integrative approaches which mine …
accelerate drug discovery and development. Especially, integrative approaches which mine …
DTMBIO 2020: The Fourteenth International Workshop on Data and Text Mining in Biomedical Informatics
Over a decade, as a specialized workshop in the field of text mining applied to biomedical
informatics, DTMBIO (ACM international workshop on Data and Text Mining in Biomedical …
informatics, DTMBIO (ACM international workshop on Data and Text Mining in Biomedical …